Home Cart Sign in  
Chemical Structure| 854847-61-3 Chemical Structure| 854847-61-3

Structure of HLY78
CAS No.: 854847-61-3

Chemical Structure| 854847-61-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HLY78 is a Wnt/β-catenin signaling pathway activator that targets the DIX domain of Axin, promoting Axin-LRP6 association and LRP6 phosphorylation, enhancing Wnt signaling. It holds significant value in the study of subarachnoid hemorrhage (SAH) and related diseases.

Synonyms: HLY78

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of HLY78

CAS No. :854847-61-3
Formula : C17H17NO2
M.W : 267.32
SMILES Code : CN1C2=C(C=CC=C2C3=CC4=C(OCO4)C=C3C1)CC
Synonyms :
HLY78
MDL No. :MFCD26961120

Safety of HLY78

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H318-H410
Precautionary Statements:P273-P280-P301+P312+P330-P305+P351+P338+P310
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT-116 cells 10 mM 48 h To evaluate the effect of HLY78 on GANT61-treated HCT-116 cells, HLY78 improved relative cell viability and reduced apoptosis PMC9478957
HT-29 cells 10 mM 48 h To evaluate the effect of HLY78 on GANT61-treated HT-29 cells, HLY78 improved relative cell viability and reduced apoptosis PMC9478957
769-P cells 10 µM 48 h By activating the Wnt/β-catenin pathway, it restored the malignant proliferation and metastasis capacity of ccRCC cells after RHBDL2 knockdown. PMC11543667
786-O cells 10 µM 48 h By activating the Wnt/β-catenin pathway, it restored the malignant proliferation and metastasis capacity of ccRCC cells after RHBDL2 knockdown. PMC11543667
Airway fibroblasts 10 µM 24 h HLY78 significantly reduced the inhibitory and pro-apoptotic effects of HSG overexpression on airway fibroblasts PMC6691245

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Subarachnoid hemorrhage model Intranasal injection 0.6 mg/kg Single administration HLY78 attenuates neuronal apoptosis and improves neurological deficits through the LRP6/GSK3β/β-catenin signaling pathway after SAH in rats. PMC7532258

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.74mL

0.75mL

0.37mL

18.70mL

3.74mL

1.87mL

37.41mL

7.48mL

3.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories